Caresyntax Secures $180M to Advance Precision Surgery Platform

Caresyntax Secures $180M to Advance Precision Surgery Platform

What You Should Know: 

Caresyntax, a leader in vendor-neutral precision surgery platforms raises $180M in funding,  comprised of $80M in equity and up to $100M in growth debt, will fuel the company’s continued growth and development of its AI-powered surgical platform.

– The funding round was led by a consortium of prominent investors, including Symbiotic Capital, MTIP AG, BIONIQ Capital, and BlackRock Innovation Capital. This significant investment demonstrates the growing demand for data-driven solutions in the surgical field.
Read on hitconsultant.net




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Nov 21, 2024 at 12:56pm